https://www.mangaloremirror.com/alumis-presents-positive-data-from-phase-2-clinical-trial-of-esk-001-an-oral-allosteric-tyk2-inhibitor-for-the-treatment-of-plaque-psoriasis-at-aad-annual-meeting/